Ascendiant Capital Markets Issues Positive Forecast for Aemetis (NASDAQ:AMTX) Stock Price

Aemetis (NASDAQ:AMTX) had its target price raised by equities researchers at Ascendiant Capital Markets from $18.00 to $19.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the specialty chemicals company’s stock.

Other analysts have also issued research reports about the stock. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, February 5th. HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research report on Friday, March 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aemetis presently has an average rating of “Hold” and an average target price of $14.56.

Aemetis Stock Down 3.4 %

NASDAQ AMTX opened at $1.97 on Monday. The company’s 50 day moving average is $2.14 and its 200-day moving average is $2.67. Aemetis has a 12-month low of $1.50 and a 12-month high of $7.03. The firm has a market cap of $100.77 million, a P/E ratio of -0.87 and a beta of 1.48.

Hedge Funds Weigh In On Aemetis

Several hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC grew its stake in Aemetis by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 934,993 shares of the specialty chemicals company’s stock valued at $2,516,000 after acquiring an additional 10,700 shares in the last quarter. State Street Corp grew its stake in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after acquiring an additional 185,304 shares in the last quarter. Jane Street Group LLC grew its stake in Aemetis by 1,130.0% during the fourth quarter. Jane Street Group LLC now owns 374,016 shares of the specialty chemicals company’s stock valued at $1,006,000 after acquiring an additional 343,609 shares in the last quarter. Northern Trust Corp grew its stake in Aemetis by 3.7% during the fourth quarter. Northern Trust Corp now owns 297,023 shares of the specialty chemicals company’s stock valued at $799,000 after acquiring an additional 10,658 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Aemetis by 515.9% during the fourth quarter. JPMorgan Chase & Co. now owns 120,716 shares of the specialty chemicals company’s stock valued at $325,000 after acquiring an additional 101,116 shares in the last quarter. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.